GE Healthcare has been a leader in the field of breast cancer detection through mammography devices since the 1960s. Today there are approximately 17,700 GE Healthcare mammography systems in use worldwide.
In 1999, GE Healthcare was the first company to introduce full-field digital mammography (FFDM). GE Healthcare estimates that since then, more than 40 million examinations have been performed with its diagnostic imaging technologies worldwide. The company has spent 13 years and more than $100 million developing the full-field digital mammography technology, GE Healthcare Senographe® systems, and continues to invest heavily in new cutting-edge technologies to detect the pathology before the onset. Approximately 3700 GE Healthcare Senographe® digital systems are currently being used in the world -- more than 90% of them still work with their original detector, far more than any other brand, proving our commitment and our reliability towards detecting breast cancer
In August this year, healthcare technology research organization KLAS ranked GE Healthcare Senographe DS as the best digital mammography system on the market today, based on a survey of healthcare providers.
Through its own research as well as partnerships with other industry innovators, GE Healthcare is continuing to bring to market advanced technologies that will help improve detection and reduce unnecessary biopsies in the future, including a magnetic resonance imaging (MRI) system specifically designed for breast imaging and tomosynthesis—currently under clinical investigation—which generates three-dimensional images.
← Back to Breast Cancer Emotion